The survival effect of prolactin on PC3 prostate cancer cells.
OBJECTIVES: Recent studies suggest a paracrine/autocrine loop involving prolactin (PRL) within the human prostate. The aims of this study were to determine the effects of PRL on the growth and survival of prostate cancer cells and the intracellular signalling mechanisms underlying such effects. MET...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2003
|
| _version_ | 1797102166100410368 |
|---|---|
| author | Ruffion, A Al-Sakkaf, K Brown, B Eaton, C Hamdy, F Dobson, P |
| author_facet | Ruffion, A Al-Sakkaf, K Brown, B Eaton, C Hamdy, F Dobson, P |
| author_sort | Ruffion, A |
| collection | OXFORD |
| description | OBJECTIVES: Recent studies suggest a paracrine/autocrine loop involving prolactin (PRL) within the human prostate. The aims of this study were to determine the effects of PRL on the growth and survival of prostate cancer cells and the intracellular signalling mechanisms underlying such effects. METHODS: The effect of PRL on proliferation of LNCaP, PC3 and DU145 was assessed by Coulter counting. The effect of PRL on TRAIL-, staurosporine- and flavopiridol-induced apoptosis was assessed by Timelapse microscopy and Annexin V binding. The status of the PRL receptor (PRL-R) and Akt/PKB (protein kinase B) activity were assessed by Western blotting. RESULTS: All three cell lines expressed both the short and long forms of the PRL receptor. Although, no significant effect of PRL on the proliferation of these cells was found, PRL partially inhibited TRAIL-induced apoptosis in PC3 cells. PRL also enhanced the phosphorylation of Akt/PKB in these cells. CONCLUSIONS: PRL had no significant effect on the proliferation of PC3, DU145 and LNCaP, but inhibited TRAIL-induced apoptosis in PC3 cells, possibly via enhanced Akt/PKB phosphorylation in PC3 cells. Further investigations are underway to determine the survival effect of PRL on the other two prostate cancer cell line. |
| first_indexed | 2024-03-07T06:02:05Z |
| format | Journal article |
| id | oxford-uuid:ec8c8b94-a128-4d7b-b48e-547bfe3affd8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:02:05Z |
| publishDate | 2003 |
| record_format | dspace |
| spelling | oxford-uuid:ec8c8b94-a128-4d7b-b48e-547bfe3affd82022-03-27T11:18:17ZThe survival effect of prolactin on PC3 prostate cancer cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ec8c8b94-a128-4d7b-b48e-547bfe3affd8EnglishSymplectic Elements at Oxford2003Ruffion, AAl-Sakkaf, KBrown, BEaton, CHamdy, FDobson, P OBJECTIVES: Recent studies suggest a paracrine/autocrine loop involving prolactin (PRL) within the human prostate. The aims of this study were to determine the effects of PRL on the growth and survival of prostate cancer cells and the intracellular signalling mechanisms underlying such effects. METHODS: The effect of PRL on proliferation of LNCaP, PC3 and DU145 was assessed by Coulter counting. The effect of PRL on TRAIL-, staurosporine- and flavopiridol-induced apoptosis was assessed by Timelapse microscopy and Annexin V binding. The status of the PRL receptor (PRL-R) and Akt/PKB (protein kinase B) activity were assessed by Western blotting. RESULTS: All three cell lines expressed both the short and long forms of the PRL receptor. Although, no significant effect of PRL on the proliferation of these cells was found, PRL partially inhibited TRAIL-induced apoptosis in PC3 cells. PRL also enhanced the phosphorylation of Akt/PKB in these cells. CONCLUSIONS: PRL had no significant effect on the proliferation of PC3, DU145 and LNCaP, but inhibited TRAIL-induced apoptosis in PC3 cells, possibly via enhanced Akt/PKB phosphorylation in PC3 cells. Further investigations are underway to determine the survival effect of PRL on the other two prostate cancer cell line. |
| spellingShingle | Ruffion, A Al-Sakkaf, K Brown, B Eaton, C Hamdy, F Dobson, P The survival effect of prolactin on PC3 prostate cancer cells. |
| title | The survival effect of prolactin on PC3 prostate cancer cells. |
| title_full | The survival effect of prolactin on PC3 prostate cancer cells. |
| title_fullStr | The survival effect of prolactin on PC3 prostate cancer cells. |
| title_full_unstemmed | The survival effect of prolactin on PC3 prostate cancer cells. |
| title_short | The survival effect of prolactin on PC3 prostate cancer cells. |
| title_sort | survival effect of prolactin on pc3 prostate cancer cells |
| work_keys_str_mv | AT ruffiona thesurvivaleffectofprolactinonpc3prostatecancercells AT alsakkafk thesurvivaleffectofprolactinonpc3prostatecancercells AT brownb thesurvivaleffectofprolactinonpc3prostatecancercells AT eatonc thesurvivaleffectofprolactinonpc3prostatecancercells AT hamdyf thesurvivaleffectofprolactinonpc3prostatecancercells AT dobsonp thesurvivaleffectofprolactinonpc3prostatecancercells AT ruffiona survivaleffectofprolactinonpc3prostatecancercells AT alsakkafk survivaleffectofprolactinonpc3prostatecancercells AT brownb survivaleffectofprolactinonpc3prostatecancercells AT eatonc survivaleffectofprolactinonpc3prostatecancercells AT hamdyf survivaleffectofprolactinonpc3prostatecancercells AT dobsonp survivaleffectofprolactinonpc3prostatecancercells |